mTOR Inhibitor Use Is Associated With a Favorable Outcome of COVID-19 in Patients of Kidney Transplant: Results of a Retrospective Study

INTRODUCTION: In solid organ transplant recipients, COVID-19 is associated with a poor prognosis because of immunosuppression. Some studies suggest a potential therapeutic role of mammalian Target of Rapamycin (mTOR) inhibitors in SARS-CoV-2 infection. This study aimed to assess the impact of mTOR e...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinchera, Biagio, Spirito, Lorenzo, Buonomo, Antonio Riccardo, Foggia, Maria, Carrano, Rosa, Salemi, Fabrizio, Schettino, Elisa, Papa, Fortuna, La Rocca, Roberto, Crocetto, Felice, Napolitano, Luigi, Villari, Riccardo, Gentile, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254357/
https://www.ncbi.nlm.nih.gov/pubmed/35801204
http://dx.doi.org/10.3389/fmed.2022.852973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254357/
https://www.ncbi.nlm.nih.gov/pubmed/35801204
http://dx.doi.org/10.3389/fmed.2022.852973

Ejemplares similares